SPY417.26+1.39 0.33%
DIA341.86+1.53 0.45%
IXIC14,052.34+13.58 0.10%

Catalyst Pharmaceuticals Q4 EPS $0.11 Beats $0.09 Estimate, Sales $31.00M Beat $30.35M Estimate

Catalyst Pharmaceuticals (NASDAQ:CPRX) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.09 by 22.22 percent. This is a 57.14 percent increase over earnings of $0.07 per share

· 03/15/2021 17:27

Catalyst Pharmaceuticals (NASDAQ:CPRX) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.09 by 22.22 percent. This is a 57.14 percent increase over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $31.00 million which beat the analyst consensus estimate of $30.35 million by 2.14 percent. This is a 2.91 percent increase over sales of $30.12 million the same period last year.